Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.7186 USD
Updated:
Apr 24, 2024
Atara Biotherapeutics Inc
Free Cash Flow
Last
Value
3-Years CAGR
5-Years CAGR
|
Atara Biotherapeutics Inc
Free Cash Flow Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Free Cash Flow
-$194.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Free Cash Flow
$22.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Free Cash Flow
$3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Free Cash Flow
$3.7B
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
24%
|
See Also
What is Atara Biotherapeutics Inc's Free Cash Flow?
Free Cash Flow
-194.2m
USD
-194.2m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Free Cash Flow amounts to -194.2m USD.
What is Atara Biotherapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
2%
2%
Over the last year, the Free Cash Flow growth was 29%. The average annual Free Cash Flow growth rates for Atara Biotherapeutics Inc have been -2% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
